Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in Korea

Clinical trial NCT01976611 · COMPLETED

Trial details

NCT number: NCT01976611
Sponsor: Allergan
Status: COMPLETED
Study type: OBSERVATIONAL

Migraine Disorders Headache

Start date: 2012-06-01
Primary completion: 2015-02-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.